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Introduction
anic disorder is a common psychiatric illness
with a lifetime prevalence of about 4.5 %.
1The hallmark
of the disorder is recurring panic attacks, which can
appear suddenly and unexpectedly. Panic symptoms
include shortness of breath, palpitations, shaking, sweat-
ing, and fear of losing control.
2 These symptoms resem-
ble those of other serious medical problems and lead
some sufferers to think they are having a heart attack or
a stroke. One of the most debilitating features of the ill-
ness is agoraphobia, a condition in which patients begin
to avoid situations and places where a panic attack and
the associated discomfort and embarrassment might
occur. Consequently, many sufferers learn to avoid daily
activities, greatly limiting their productivity and quality
of life. Major depression often co-occurs.
3When severe,
these symptoms can be debilitating, particularly for the
large number of patients who are refractory to current
therapies. Identifying new therapies may require under-
standing of why panic attacks occur and what triggers
them, knowledge that is currently lacking (see Box
below). Crucial advances might be made if panic attacks
could be evoked in the laboratory so that the underlying
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Panic disorder is a common and disabling illness for which
treatments are too frequently ineffective. Greater knowl-
edge of the underlying biology could aid the discovery of
better therapies. Although panic attacks occur unpre-
dictably, the ability to provoke them in the laboratory
with challenge protocols provides an opportunity for cru-
cial insight into the neurobiology of panic. Two of the
most well-studied panic provocation challenges are CO2
inhalation and lactate infusion. Although it remains
unclear how these challenges provoke panic, animal mod-
els of CO2 and lactate action are beginning to emerge,
and offer unprecedented opportunities to probe the mol-
ecules and circuits underlying panic attacks. Both CO2 and
lactate alter pH balance and may generate acidosis that
can influence neuron function through a growing list of
pH-sensitive receptors. These observations suggest that a
key to better understanding of panic disorder may lie in
more knowledge of brain pH regulation and pH-sensitive
receptors.  
© 2011, LLS SAS Dialogues Clin Neurosci. 2011;13:475-483.
PAGES_12_AG_1005_BA.qxd:DCNS#51  1/12/11  14:54  Page 475mechanisms might be deconstructed. This review dis-
cusses progress based on this approach, which raises the
possibility that brain pH and pH-sensitive receptors may
contribute to the pathophysiology of panic disorder. 
Panic provocation
Provocation challenges offer potential for unique
insights into panic
Panic disorder is relatively unique among psychiatric ill-
nesses, in that symptoms resembling the illness can be
provoked by a number of chemicals called panicogens.
Because naturally occurring panic attacks are unpre-
dictable, the ability to induce an attack becomes a pow-
erful tool for research. Moreover, the biological mecha-
nisms of the panicogens themselves might tell us a lot
about the neurobiology of the illness. Therefore, it has
long been hoped that provocation challenges might shed
light on the mechanisms underlying panic. Examples of
agents with the potential ability to evoke panic attacks
include carbon dioxide (CO2),
10,11 sodium lactate,
12
doxapram,
17 cholecystokinin (CCK-4) and related ago-
nists,
18,19 flumazenil,
20 caffeine,
21 adrenergic agonists (iso-
proterenol, yohimbine, epinephrine),
19 serotonin receptor
activators (d-fenfluramine, metachlorophenylpiperazine
(m-CPP),
19 and perhaps opioid receptor antagonists.
22,23
The symptoms provoked by these agents can closely
resemble naturally occurring attacks.
19,24 Unfortunately,
many of these provocation challenges have been studied
too little to ascertain their mechanisms of action and rel-
ative potency.
19,25 Interestingly, one twin study found a high
concordance rate for CO2 sensitivity, 
26 suggesting a
genetic etiology, although much remains to be learned
about the heritability of panicogen sensitivity.
Rodent models of panic provocation challenges
The technology revolutionizing neurobiological research
in rodents is rapidly expanding knowledge of mecha-
nisms underlying behavior. The ability to explore pan-
icogens in animal models provides a powerful research
opportunity. However, progress in this area has been
limited in comparison with the advancements made in
other behavioral models. Yet, several examples are
notable. Shekhar and colleagues have developed rodent
models of lactate-evoked panic
27,28 and have found that
orexin-expressing neurons in the hypothalamus play a
critical role.
29 In another example, doxapram potentiated
fear and anxiety-related behaviors in rats and induced
expression of the immediate early gene c-Fos in the
amygdala.
30 A few investigators have also begun to
explore the effects of CO2 on fear and anxiety in
rodents.
31-33 For example, Mongeluzi et al found that high
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Theories of panic etiology
Although the mechanisms for panic remain obscure, several theories provide useful foundations for conceptu-
alizing the bases of the attacks: (i) Some theories focus on cognitive distortions and misinterpretations of somatic
experiences. For example, sensing one’s heartbeat may be misinterpreted as an impending heart attack, trigger-
ing uncontrolled fear (reviewed in ref 4). (ii) Other theories focus on ventilation. Klein’s false suffocation alarm
theory highlights the similarities between panic attacks and the powerful fear that suffocation evokes; this the-
ory posits that a “suffocation alarm” is falsely triggered, thus inadvertently producing panic.
5 Interestingly, patients
with a history of respiratory disease have a greater risk of panic disorder than the general population.
6-8 Similarly,
panic disorder patients with prominent respiratory symptoms were more likely to have a prior history of respi-
ratory insult.
9Thus, previous experience and adaptive plasticity and/or conditioning might play a role in panic.
13
(iii) Growing knowledge of the anatomy underlying fear conditioning led Gorman and others to speculate that
a supercharged fear circuit could produce panic in response to a wide variety of arousing stimuli.
14,15This fear cir-
cuit is thought to include at least 5 components: (i) Sensory input from viscera via the nucleus of the solitary tract
and sensory thalamus. (ii) Processing and conscious control via the prefrontal cortex, cingulate cortex, and insula.
(iii) Processing context and fear through the hippocampus and amygdala. (iv) Coordinated output of behavioral,
autonomic, and neuroendocrine manifestations from the amygdala via the hypothalamus, periacqueductal gray,
locus coeruleus, and parabrachial nucleus.
14,16 (v) modulation by monoamines including serotonin and the raphe
nuclei.
14 Supporting this final component is the well-established benefit of selective serotonin reuptake inhibitors. 
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ulus in Pavlovian fear conditioning.
31 Johnson et al
observed that CO2 inhalation can induce c-Fos expres-
sion in fear circuit structures and may thus activate brain
regions thought to be responsible for panic.
33 Despite
these examples, the mechanisms underlying panicogen
action and panic attacks remain largely unknown. 
Clinical clues about panicogen action
Perhaps the most well-studied panicogens are CO2 and
lactate. CO2 provocation challenges vary between inves-
tigators, but generally consist of breathing single or mul-
tiple breaths of CO2 at concentrations ranging from 5%
to 35%.
24 Protocols for lactate provocation challenges
typically include intravenous infusion of 0.5 M sodium
D,L-lactate up to 10 mg/kg body weight over 20 minutes
or until panic occurs.
12,19,34 Several observations led inves-
tigators to suggest that CO2 and lactate may share mech-
anisms of action.
35 For example, most CO2-sensitive pan-
ickers are also lactate-sensitive.
36 In addition, CO2 and
lactate produce stereotypic responses. In particular both
induce prominent ventilatory symptoms, suggesting a
degree of neuroanatomical or physiological overlap.
37,38
Interestingly, both CO2 and lactate may be more likely
to affect panic disorder patients who report strong res-
piratory symptoms during their naturally occurring
attacks.
38,39 CO2 and lactate may also induce less hypo-
thalamus-pituitary-adrenal (HPA) axis activation than
other panicogens,
40-42 suggesting that their effects may be
cortisol-independent. Consistent with this observation,
inhibiting cortisol synthesis failed to prevent CO2-
evoked panic.
43 Furthermore, both CO2 and lactate play
prominent roles in metabolism and share the potential
to alter systemic acid-base balance. 
Panic and acid-base balance
CO2 and brain acidosis
CO
2 is constantly produced in the brain and throughout
the body as a final product of carbohydrate metabolism.
CO
2 readily crosses cell membranes and the blood-brain
barrier. In a reaction catalyzed by carbonic anhydrase,
CO
2 is hydrolyzed to carbonic acid (H2CO3), which read-
ily dissociates into HCO3– and H
+. The resulting acido-
sis is thought to be responsible for most of the physio-
logical effects of CO2,
44 including stimulating
acid-activated respiratory chemoreceptors in the brain
stem.
45 These chemoreceptors stimulate breathing to
expel CO2 and thus correctively raise systemic pH.
Inhaling CO2 increases the partial pressure of CO2 in the
blood and lowers pH throughout the body. Thus, the
CO2 provocation challenges used in psychiatric research
are likely to acutely and transiently acidify brain pH.
Lactate and brain acidosis
Endogenous lactate is generated by glucose and glyco-
gen metabolism. In the brain, astrocytes are thought to
convert glucose and stored glycogen into lactate, which
is exported to the interstitial space where it can be taken
up by neurons to produce energy via oxidative metabo-
lism.
46 Recent experiments suggest that shuttling lactate
to neurons may be crucial for learning and memory.
47
The effects of intravenous lactate on systemic pH are
more complex than those of CO2. One reason is that
intravenously administered lactate can be metabolized
by the liver to HCO3–, which might raise blood pH. In
addition, in order to cross membranes such as the blood-
brain barrier, lactate requires monocarboxylate trans-
porters (MCTs). Because these MCTs cotransport H
+,
they effectively move lactic acid, thus providing a mech-
anism that might lower pH in specific compartments, for
example in the central nervous system (CNS). A recent
review covers these complex effects of lactate on sys-
temic pH.
35 Importantly, intravenous lactate causes
hyperventilation,
48 suggesting that, like CO2 inhalation,
lactate likely reduces pH at ventilatory chemoreceptors
and perhaps elsewhere in the brain.
49These observations
suggest that CO2 and lactate may share an ability to
acidify interstitial pH in the brain. Interestingly, another
panicogen, doxapram, may act by a related mechanism.
Both doxapram and protons stimulate ventilation and
both can inhibit two-pore domain K
+ channels (TWIK)-
related acid-sensitive K
+ (TASK) channels.
50,51
pH abnormalities in panic disorder?
Increasing evidence suggests that pH may be abnormally
regulated in panic disorder.
35,44 Brain pH is largely con-
trolled by the CO2/HCO3– buffering system, which is
acutely regulated by breathing. Multiple investigators
have reported irregular breathing in panic disorder,
52-55
including greater tidal volume variability, which may be
due to more frequent sighing.
52 Consistent with a persis-
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exhibit a chronically low end-tidal CO2
56-59 and a com-
pensatory decrease in serum bicarbonate.
2,59 Those who
exhibit breathing irregularities may also be more likely
to have respiratory symptoms during an attack.
38,60
Symptom cluster analyses have identified a subtype of
panic disorder, in which respiratory symptoms appear to
predominate.
38,60 Interestingly, the respiratory subtype
may be the most sensitive to CO2
38 and lactate.
39 This
subtype may also respond best to the antidepressant
imipramine,
60 and may be more likely to be associated
with a family history of panic disorder.
38 Supporting a
role for pH in panic pathophysiology, correcting blood
gas abnormalities through breathing control or phar-
macology has been suggested to produce clinical
improvement.
57,59
Endogenous lactate and pH abnormalities in panic 
disorder
Lactate is a weak acid that can be an independent deter-
minant of pH in biological systems.
61 Several studies
using 
1H-magnetic resonance spectroscopy suggest
endogenous lactate levels may be elevated in panic dis-
order patients. Panic disorder patients had higher lactate
levels than controls in response to visual cortex activa-
tion,
62 following hyperventilation,
63 and during lactate-
induced panic.
49 Fiberoptic biosensor measurements of
pH in primates suggest that intravenous lactate infusion
reduces brain pH.
64 Phosphorus spectroscopy further
suggests that the elevated brain lactate in panic disorder
patients may change pH buffering capacity.
65 It was sug-
gested that a vascular or metabolic abnormality might
be responsible for the lactate elevation.
49,53,62 Consistent
with this view, probands who had a family history of
panic and an atypical CO2 ventilatory response were
more likely to carry a polymorphism in a gene encoding
lactate dehydrogenase, which catalyzes the conversion
of lactate to pyruvate.
53
CNS chemosensitivity
CO2 and acid chemosensitivity in the CNS
The potential associations between panic disorder, the
action of panicogens, and brain pH begs the question of
how the brain normally senses and responds to pH
change. The majority of research on chemosensitivity in
the CNS has focused on respiratory control. Thus,
understanding how pH regulates breathing could pro-
vide critical insights into panic disorder. Breathing rate
and volume are exquisitely sensitive to CO2 in the
blood, largely through interstitial pH and activation of
pH-sensitive chemoreceptors.
45,66 Although the precise
sites of CO2-mediated ventilatory control are uncertain,
they are thought to lie in the brain stem
67 (medulla and
pons). Neurons in multiple brain stem sites can be acti-
vated by CO2 and low pH, suggesting the relevant
chemosensitivity might reside at multiple locations.
67-69
The retrotrapezoid nucleus (RTN) of the medulla has
been implicated in respiratory chemosensation, partic-
ularly the cells expressing Phox2b, which is mutated in
congenital hypoventilation syndrome.
67,70 Other brain-
stem nuclei are sensitive to pH and have been impli-
cated in pH-mediated ventilatory control; these regions
include the medullary raphe nuclei, nucleus of the trac-
tus solitarius, and locus coeruleus.
67,69,71 Thus, multiple
chemosensitive sites are possible. The CO2 sensitivity in
panic patients, and the associations between panic and
ventilation, make it tantalizing to speculate that abnor-
malities in these chemosensitive neurons and receptors
might contribute to panic attacks. Knowledge of pH-
sensitive molecules in the brain and their physiological
roles is rapidly growing, but much remains to be
learned.
pH-sensitive receptors and respiratory chemosensation
Understanding the molecules that underlie pH effects
on ventilatory control could pave the way for under-
standing pH sensitivity in the brain in general. Thus far
no single molecule has been found to be responsible for
respiratory chemosensation. A number of molecules
have the potential to detect falling pH and stimulate
breathing.
72 Members of the TWIK family are pH-sensi-
tive
73; a subset, the TASK channels, have garnered atten-
tion as potential respiratory chemoreceptors. Because
TASK channels help maintain membrane voltage near
the resting potential, inhibiting these channels increases
excitability and the likelihood of generating action
potentials. TASK channels can be inhibited by small
reductions in extracellular pH. For example, reducing
pH by just 1/10th of a unit from pH 7.4 to pH 7.3 inhibits
TASK-1.
73TASK-1 and TASK-3 are widely expressed in
brain,
74 while TASK-2 expression in brain is limited to a
few brain stem nuclei, including the retrotrapezoid
Translational research
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of ventilation. Nevertheless, disrupting the genes encod-
ing TASK-1, TASK-2, or TASK-3 in mice failed to elim-
inate the centrally mediated hypercapnic ventilatory
response,
74-76 suggesting that the TASK channels are not
required. However, some pH-sensitive responses were
affected. Loss of TASK-1, TASK-3, or both reduced the
pH sensitivity of cultured raphe neurons, but not that of
RTN neurons.
74TASK-1 disruption also reduced periph-
eral chemosensitivity to hypercapnia in the carotid
body.
75 Additionally, TASK-2 disruption in mice
increased the respiratory response to mild hypercapnia
(1.5 and 2% CO2), suggesting a modulatory role.
76
pH-sensitive ion channels, G-protein coupled 
receptors, and intracellular signaling molecules
Besides the TASK channels, a wide number of additional
molecules might sense pH in the brain. Examples of pH-
sensitive ion channels include transient receptor poten-
tial (TRP) channels,
77 P2X receptors,
78,79 voltage-depen-
dent Ca
2+ channels,
80 N-methyl-D aspartate (NMDA)
receptors,
81 acid-sensing ion channels (ASICs),
82-84 and
inward rectifier K
+ channels.
85 Examples of pH-sensitive
G-protein coupled receptors include OGR1, GPR4,
TDAG8, adenosine A1 receptors, and metabotropic P2Y
receptors.
72,78,86 pH-sensitive intracellular signaling mole-
cules include Pyk2 and soluble adenlyl cyclase (sAC).
72
All of these molecules are sensitive enough to detect pH
changes that occur during physiology or pathophysiol-
ogy. Further, all of these molecules have been suggested
as candidates for pH chemosensitivity.
72,86 Though more
investigation is needed, some of these molecules have
already been implicated in pH sensing. For example,
voltage-dependent Ca
2+ channels and NMDA receptors
modulate synaptic plasticity in response to changes in
extracellular pH.
80,81Adenosine A1 receptors, adenosine
triphosphate (ATP) receptors (P2X and P2Y), and
ASIC1a have been implicated in the ability of CO2 and
low pH to inhibit seizure activity.
32,78 Recent studies also
investigated the potential role in the inward rectifier K
+
channel Kir5.1, which is highly sensitive to extracellular
pH when heteromerically coupled to Kir4.1. Disrupting
Kir5.1 produced abnormal respiration and metabolic
acidosis in mice, however central hypercapnic ventila-
tory responses remained intact. Instead, impaired sen-
sory afferent nerve conduction was thought to be
responsible for the abnormal respiratory phenotype.
85
Effects of chemosensation on arousal and emotion 
circuits
pH-sensitive respiratory chemosensors in the brain stem
medulla and pons comprise a powerful mechanism for
controlling systemic CO2 and pH. Slow or shallow
breathing acidifies systemic pH, while fast or deeper
breathing raises systemic pH, making it more alkaline.
There may also be a need for higher level (more rostral)
brain structures to monitor pH, for example to produce
appropriate cognitive or behavioral responses to rising
CO2. Rising CO2 heralds the potential threat of suffo-
cation, a terrifying situation that demands immediate
detection and action to ensure survival. The clusters of
pH-sensitive neurons in the medulla and pons that stim-
ulate breathing might communicate this need for action
to higher level structures. Alternatively, it might be
advantageous if sites above the medulla and pons sensed
pH more directly.
68,69 A prominent example is midbrain
serotonergic neurons. Midbrain raphe neurons are
highly pH-sensitive and increase firing when CO2 rises
and pH falls.
87 These neurons are well positioned to
deliver serotonin (5-HT) to forebrain, cortical, and sub-
cortical structures and thus alter mood and cognition in
response to CO2 and low pH. In sleep, a rising CO2 and
falling pH might signal the need to reposition the airway
or to relieve an obstruction. During sleep CO2 inhala-
tion causes wild-type mice to wake up, whereas CO2 fails
to wake mice lacking pH-sensitive serotonin neurons.
88
Thus, dysfunction of these neurons might play a critical
role in sudden infant death syndrome,
89 where a failure
to wake may lead to suffocation. Neurons in even higher
order brain areas are also activated by low pH, includ-
ing orexin-expressing neurons in the hypothalamus.
90
These orexin-expressing neurons have been implicated
in narcolepsy and arousal, and are positioned to influ-
ence diverse physiological functions including adaptive
behaviors, metabolism, respiration, and panic.
29 Recently
the amygdala was also implicated in CO2 and acid
chemosensation and CO2-evoked fear.
32
The amygdala is a chemosensor that detects CO2 and
acidosis to elicit fear
It is well established that the amygdala integrates sen-
sory input from other brain structures to orchestrate fear
behavior; however, the amygdala itself was not previ-
ously known to act as a pH sensor. Ziemann et al sus-
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ing ion channel-1a (ASIC1a) was abundantly expressed
in the basolateral amygdala and other fear circuit struc-
tures,
91,92 and it was found that breathing 10% CO2 low-
ered pH to levels sufficiently to activate ASIC1a in
amygdala neurons.
32 To test CO2-triggered fear in mice,
four behavioral paradigms were developed: (i) CO2-
evoked freezing; (ii) CO2-potentiated center avoidance
in the open field; (iii) CO2 aversion; and (iv) CO2-
enhanced fear conditioning.
32 Genetically disrupting or
pharmacologically inhibiting ASIC1a reduced fear-like
behavior in these paradigms.
32 Particularly striking was
the freezing behavior, which is often used as a correlate
of fear and panic in mice. Like other fear-evoking stim-
uli, breathing 10% CO2 induced a dramatic freezing
response in wild-type mice. Disrupting or inhibiting
ASIC1a significantly blunted this response.
32 To test
whether the amygdala itself might sense pH, acidic arti-
ficial cerebrospinal fluid was microinfused into the
amygdala to lower pH to ~6.8 from normal pH 7.35.
Acidifying the amygdala produced freezing behavior in
wild-type mice that resembled the freezing evoked by
CO2 inhalation. Interestingly, in the ASIC1a knockout
mice amygdala acidosis induced little or no freezing. The
freezing deficit was likely specific to low pH because the
ASIC1a knockouts froze normally when the amygdala
was electrically stimulated. Finally, the authors tested
whether ASIC1a in the amygdala might be sufficient to
produce CO2-evoked freezing. Restoring ASIC1a
expression to the amygdala of ASIC1a-null mice with an
ASIC1a-expressing adeno-associated virus corrected the
CO2-evoked freezing deficit (Figure 1). Together these
findings suggest that the amygdala itself can act as a
chemosensor. These experiments further identify
ASIC1a as key molecular mediator of this chemosensi-
tive response. 
Interoception and false alarms
It is intriguing that a brain structure that mediates fear
has a chemosensory role. The ability to sense or monitor
internal bodily states (interoception) is a common
human experience, ranging from vague sensations to
powerful and uncontrollable emotions. Often the lan-
guage needed to communicate these sensations seems
inadequate. Yet, interoceptive sensations may be critical
for survival. pH might be one of a variety of signals that
could produce interoceptive sensations by activating pH-
Translational research
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Figure 1. Expressing acid-sensing ion channel (ASIC)1a bilaterally in the
basolateral amygdala of ASIC1a knockout (ASIC1a–/–) mice
increased CO2-evoked freezing behavior. (a) Examples of adeno-
associated virus vector (AAV) injections that led to ASIC1a
expression or enhanced green fluorescent protein (GFP) expres-
sion bilaterally in the amygdala of ASIC1a–/– mice. ASIC1a
expression was detected by immunohistochemistry using an
antibody against the carboxy-terminus of the channel protein.
GFP fluorescence is shown below. Non-virus-transduced tissue
is shown to the right for comparison. (b) CO2 evokes freezing
behavior in wild-type mice, which depends on ASIC1a. Mice
lacking ASIC1a have a significantly attenuated freezing response.
However, transducing the basolateral amygdala (BLA) bilaterally
with an AAV vector expressing ASIC1a (ASIC1a-hit) increased
CO2-evoked freezing. Injections with a virus expressing only
eGFP or injections that missed the amygdala did not increase
CO2-evoked freezing. *P<0.001, ASIC1a-hit group relative to
other ASIC1a–/– groups. This experiment suggests that the baso-
lateral amygdala is likely to be an important site of ASIC1a action
in CO2-evoked behavior. It further suggests that the amygdala
plays a role in chemosensation.
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responses. The survival value of rapidly detecting CO2
to prevent suffocation seems clear. Nearly 20 years ago
Donald Klein drew from this observation to hypothesize
that the suffocation detection system might be falsely
triggered to produce panic attacks.
5 Conceivably, height-
ened pH sensitivity could constitute such a false alarm.
Summary
We don’t yet know why panic attacks occur. Nor do we
completely understand why those who suffer panic
attacks are hypersensitive to panicogens. However, the
potential ability of CO2 and lactate, the two most well-
studied panicogens, to alter brain pH suggests that pH
chemosensation could be instrumental. Acid-sensitive
molecules are widely distributed in fear circuit structures
and elsewhere in the brain. Consistent with this obser-
vation, a variety of brain sites have been implicated in
pH chemosensation including brain stem respiratory
nuclei, midbrain raphe neurons, hypothalamus, and
amygdala. However, a number of questions remain. For
example, what specific role(s) do each of these pH-sen-
sitive sites and pH-sensitive molecules play? Could there
be additional sources of acidosis and pH fluctuation
besides CO2 or lactate that might activate these
chemosensory pathways? Finally, might genetic or epi-
genetic variability in chemosensation lead to panic dis-
order or other psychiatric and neurological illnesses?
That we are now in a position to ask these questions is
in itself a significant advance. As we continue to learn
more about CO2 and pH chemosensation in the brain,
the answers to these questions may be within reach.
Moreover, an improved understanding of pH signaling
and dysregulation might very well lead to an entirely
new avenue of therapeutic intervention.  ❏
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